相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1
Ying Wang et al.
CANCER RESEARCH (2014)
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
Brittany C. Parker et al.
JOURNAL OF PATHOLOGY (2014)
BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
Sayem Miah et al.
PLOS ONE (2014)
NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
Meike Wagner et al.
BMC CANCER (2013)
Mining breast cancer genes with a network based noise-tolerant approach
Yaling Nie et al.
BMC SYSTEMS BIOLOGY (2013)
The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1
Raghuveera K. Goel et al.
FEBS JOURNAL (2013)
Identifying protein interaction subnetworks by a bagging Markov random field-based method
Li Chen et al.
NUCLEIC ACIDS RESEARCH (2013)
HINT: High-quality protein interactomes and their applications in understanding human disease
Jishnu Das et al.
BMC SYSTEMS BIOLOGY (2012)
Studying protein-protein interaction networks: a systems view on diseases
Ferenc Jordan et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2012)
The Emerging Paradigm of Network Medicine in the Study of Human Disease
Stephen Y. Chan et al.
CIRCULATION RESEARCH (2012)
Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
R. Nahta
CURRENT MEDICINAL CHEMISTRY (2012)
Mutual exclusivity analysis identifies oncogenic network modules
Giovanni Ciriello et al.
GENOME RESEARCH (2012)
Transcriptional Regulation of the Human Tumor Suppressor DOK1 by E2F1
Maha Siouda et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
Chandra Bartholomeusz et al.
ONCOLOGIST (2012)
RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
Florence Le Calvez-Kelm et al.
PLOS ONE (2012)
Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
Christof Winter et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
Luisel J. Ricks-Santi et al.
BMC CANCER (2011)
Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2
Sreenivasan Paruthiyil et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Network-based methods for human disease gene prediction
Xiujuan Wang et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2011)
TGF-β Signaling Pathway and Breast Cancer Susceptibility
Serena Scollen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer
Pierre-Luc Mercier et al.
MOLECULAR ONCOLOGY (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
ConsensusPathDB: toward a more complete picture of cell biology
Atanas Kamburov et al.
NUCLEIC ACIDS RESEARCH (2011)
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
David Venet et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Protein Networks as Logic Functions in Development and Cancer
Janusz Dutkowski et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer Promising Clinical Target or Only a Marker?
Monika L. Burness et al.
CANCER JOURNAL (2010)
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
Xin An et al.
LEUKEMIA RESEARCH (2010)
Identification of DOK genes as lung tumor suppressors
Alice H. Berger et al.
NATURE GENETICS (2010)
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Yang Li et al.
NATURE MEDICINE (2010)
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination
Remi Buisson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
Jeran K. Stratford et al.
PLOS MEDICINE (2010)
Triple-negative breast cancer-current status and future directions
O. Gluz et al.
ANNALS OF ONCOLOGY (2009)
Dynamic modularity in protein interaction networks predicts breast cancer outcome
Ian W. Taylor et al.
NATURE BIOTECHNOLOGY (2009)
Prognostic gene signatures for non-small-cell lung cancer
Paul C. Boutros et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Network Analysis in the Social Sciences
Stephen P. Borgatti et al.
SCIENCE (2009)
Network modeling links breast cancer susceptibility and centrosome dysfunction
Miguel Angel Pujana et al.
NATURE GENETICS (2007)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tamoxifen-induced ER-α-SRC-3 interaction in HER2 positive human breast cancer;: a possible mechanism for ER isoform specific recurrence
Marie Mc Ilroy et al.
ENDOCRINE-RELATED CANCER (2006)
Global topological features of cancer proteins in the human interactome
Pall F. Jonsson et al.
BIOINFORMATICS (2006)
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
Divyamani Srinivasan et al.
CANCER RESEARCH (2006)
Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues
S Wachi et al.
BIOINFORMATICS (2005)
Crystal structure of a Rad51 filament
AB Conway et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh et al.
CANCER CELL (2002)
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
A Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of Rad51 alteration in patients with bilateral breast cancer
M Kato et al.
JOURNAL OF HUMAN GENETICS (2000)
分享论文
